BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Metabolic Solutions Development Company Reports Positive Top-Line Results From Phase 2a Study of its Second Compound to Treat Type 2 Diabetes

  September 9, 2011

   · 

  3 min read
• BioForest

  Theraclone Sciences, Inc. Snaps Up $10.6 Million Financing

  September 9, 2011

   · 

  1 min read
• BioMidwest

  Medicis Won’t Sell Fat-buster in the US Despite FDA OK

  September 9, 2011

   · 

  1 min read
• Policy

  Servier Faces Another Scandal Over Another Drug

  September 9, 2011

   · 

  1 min read
• Drug Development

  Roche Starts Early Stage Clinical Trial in Down Syndrome

  September 9, 2011

   · 

  3 min read
• BioMidwest

  AtriCure, Inc.: Is Now the Time for a Strategic Acquirer to Step Up?

  September 9, 2011

   · 

  1 min read
• FDA

  FDAAdvisoryCommittee.com Grants Fluke Biomedical 510(k) Clearance for New ProSim(TM) Vital Signs Simulators

  September 9, 2011

   · 

  2 min read
• Business

  Crescendo Bioscience Pockets $56 Million and Gives Buyout Option to Myriad Genetics, Inc.

  September 9, 2011

   · 

  3 min read
• Drug Development

  National Institute for Clinical Excellence (NICE) Questions Merck & Co., Inc., Nycomed COPD Drug

  September 9, 2011

   · 

  1 min read
• BioMidwest

  Unsuccessful Stryker Corporation Brain Stent Shows Flaws in Device Development, Approval

  September 9, 2011

   · 

  1 min read